Learn how joint pain patients are seeing a 90%+ success rate* in our 4 month at-home regenerative protocol
Knees, hips, shoulders, necks and backs. No traveling to a clinic, no joint replacement surgery, no months of downtime. Two board-certified physicians break down the cell-free Ultra RSF Pro protocol, which joints tend to respond, who qualifies, and how the whole thing is guided from your living room.
Your 90 minutes, mapped out.
One session, four parts, then live Q&A. Here is exactly what happens and when.
Why joint pain treatments keep falling short
- Where cortisone shots, gel injections, physical therapy and joint replacement actually help, and exactly where each one stops.
- Why so many knee, hip and shoulder patients cycle through the same treatments for years without resolution.
- What changes when you treat a worn joint at the signaling level instead of managing the pain around it.
Signaling-first regenerative medicine, explained
- What Ultra RSF Pro is, and why cell-free, DNA-free and RNA-free matters for joint tissue.
- Why it draws signaling factors from six placental regions instead of a single source.
- How this differs from the knee and shoulder “stem cell shots” most patients have been quoted.
Real joint patient cases, in their own words
- Knee, shoulder and back patients walking through what their protocol actually looked like.
- Honest talk about which joints respond well and who this approach is not the right fit for.
- What our physicians look for on an application, including where imaging matters.
The 4 month at-home protocol, start to finish
- Physician evaluation, a plan built around your specific joint, and guided in-home treatment.
- Ongoing telehealth monitoring and how the plan adjusts as you progress.
- Then live Q&A: bring your questions and get them answered on the call.
Every one of them started where you are now.
What, when, and where.
A 100% free live training for people living with joint pain, where two regenerative medicine physicians explain the Ultra RSF Pro protocol in plain English, then answer your questions live.
This Saturday, September 19 at 2:00 PM EST. Approximately 90 minutes, including the live Q&A block at the end.
Hosted online, join from anywhere. Your link arrives by email and text.
Two physicians, one protocol.
Dr. Greg Carder
Dr. Carder reviews patient applications personally and leads the clinical side of the Regen MDs protocol. On the training he walks through the science behind signaling-first regenerative medicine and what separates it from the shots, scopes and replacements most joint patients have already tried.
Dr. Mick Emandi
Dr. Emandi leads Regen MDs and built the at-home care model that lets patients complete the full protocol without traveling. He covers which joints qualify, what the 4 month program involves week to week, and takes questions live on the call.
Seats are limited so every question gets answered.
Live, this Saturday, September 19 at 2:00 PM EST. Your access link is sent to your email and phone the moment you register.
© 2026 Regen MDs. All rights reserved.
*About the 90%+ Figure: The 90%+ success rate referenced on this page reflects internal clinical observations of patients who completed the full 4 month Regen MDs protocol as directed, where success was defined as patient-reported improvement in their primary complaint. This figure is based on clinical observation, not a randomized controlled clinical trial, and it has not been independently verified. It is not a guarantee or prediction of your results. Individual results vary, and some patients experience little or no improvement.
Testimonials: Patients appearing on this page are describing their own experience. Individual results vary and are not a guarantee of outcome. Like all medical procedures, regenerative therapies have a success and failure rate.
Medical Disclaimer: The information on this page and in the training is provided for general informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for advice from your own physician. Candidacy is determined by a licensed physician, every applicant is reviewed individually, and we only move forward with patients we believe we can genuinely help. Regenerative and cellular therapies have not been approved by the FDA for the treatment of any specific disease or condition. Statements on this page have not been evaluated by the Food and Drug Administration.
This site is not a part of the Facebook website or Meta Platforms, Inc. Additionally, this site is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of Meta Platforms, Inc.